SEC Filing Analysis: Annovis Bio, Inc. (ANVS)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director exercised options to acquire 7,142 shares, a routine transaction with negligible financial impact.
• Market Impact: Neutral. The transaction is too small to influence market sentiment or trading volume.

Company Information

Field	Value
Company	Annovis Bio, Inc.
Ticker Symbol	ANVS
CIK	0001477845
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	Bruck Claudine
CIK	0001733680
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-09-10
Transaction Code	M (Option Exercise)
Security Type	Common Stock
Shares Involved	7,142
Price Per Share	$0.14
Total Value	$999.88
Shares Owned After	13,709
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$999.88
% of Market Cap	<0.01%
Shares Transacted	7,142
% of Shares Outstanding	0.037%
Post-Transaction Ownership	13,709 shares (0.07% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value of approximately $1,000 is insignificant for a company with a $50 million market capitalization.
• Ownership Concentration: The director's post-transaction ownership remains very low at 0.07% of total shares outstanding.
• Dilution Impact: The exercise of 7,142 options has a negligible dilutive effect, representing only 0.037% of the shares outstanding.
• Transaction Significance: The transaction is classified as low significance as it falls well below the materiality thresholds of 0.1% of market cap and 0.1% of shares outstanding.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a routine exercise of options acquired long ago, not a discretionary open-market purchase reflecting current sentiment. The size is immaterial.

Volume & Sentiment

• Expected Volume Impact: None. The transaction is too small to affect trading volume.
• Sentiment Indicator: Neutral. Option exercises are generally not considered strong sentiment indicators unless paired with a large, immediate sale.

Additional Context

Transaction Notes

• The transaction involved exercising options that were set to expire on September 18, 2025. This is a standard action taken by insiders to realize value from vested options before expiration.